Hikvision Announces New Business Team to Develop Intelligent Solution for Fentanyl-related Substances Regulation
Hangzhou Hikvision Digital Technology Co., Ltd (“Hikvision”) today announced a new business team dedicated to developing intelligent solutions for fentanyl-related substances regulation. This is a significant move to respond and contribute to the joint efforts between the governments of China and the U.S., along with the international community, to combat drug crimes and protect public health and safety. Relying on Hikvision’s advanced video technology and big data analytics, the newly dedicated team will be committed to developing intelligent solutions for fentanyl regulation.
In recent years, efforts to effectively regulate and control new types of psychoactive substances, including fentanyl, has become a serious international problem. In late 2018, the leaders and governments of China and the U.S. reached an agreement on the cooperation of law enforcement and fentanyl control. Recently, China’s Ministry of Public Security, National Health Commission, and National Medical Products Administration jointly announced regulation on all fentanyl-related substances as a class of controlled substances (with non-medical use), which takes effect May 1, 2019.
Due to its numerous variants and low threshold for synthesis, fentanyl has put forward a new challenge for drug inspection and control technology. Hikvision’s new team is composed of experts in many fields including system architecture, central platforms, algorithms, and products. With experience in intelligent video applications and big data analytics, the team will conduct in-depth research on key technical issues existing in fentanyl’s production, storage and transportation, and develop customized intelligent solutions to optimize drug control.
Mr. Cai Changyang, senior VP of Hikvision, said: "Creating more value for society through our advanced technology has always been a goal Hikvision pursued. The problem is new types of drugs, including fentanyl-related substances, have caused risks and hazards worldwide. Therefore, the company has decided to set up a dedicated team to respond to the challenge with our joint endeavor, aiming to make contributions to protect the physical and mental health of humanity, as well as safeguard our communities and society."
Newsroom
Explore the latest news, customer stories, and industry insights from Hikvision
Hikvision.com uses strictly necessary cookies and related technologies to enable the website to function. With your consent, we would also like to use cookies to observe and analyse traffic levels and other metrics / show you targeted advertising / show you advertising on the basis of your location / tailor our website's content. For more information on cookie practices please refer to our cookie policy.
Product Selector
Core Technologies
Legacy Products
Hikvision License Activation
Hikvision App Store
